Format

Send to

Choose Destination
J Allergy Clin Immunol. 2017 May;139(5):1698-1701. doi: 10.1016/j.jaci.2016.10.022. Epub 2016 Nov 19.

Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.

Author information

1
Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Md. Electronic address: scott.canna@chp.edu.
2
Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland.
3
Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Md.
4
Children's Hospital of Philadelphia, Philadelphia, Pa.
5
AB2Bio, Ltd, Lausanne, Switzerland.

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center